Granules India Limited has informed the Exchange regarding a press release dated February 24, 2021, titled "Granules India Limited announces approval of Acetaminophen, Aspirin and Caffeine Tablets (OTC), generic equivalent of Excedrin Migraine Tablets of GlaxoSmithKline Consumer Healthcare".
Press Release Feb 24 2021
Filed with NSE · · 3 pages · English
Release
Earlier from Granules India
- Press Release Feb 17 2021
- Press Release Feb 01 2021
- Press Release Jan 13 2021
- Press Release Dec 03 2020
- Press Release Oct 22 2020
Later from Granules India
- Press Release Jul 21 2021
- Press Release Aug 30 2021
- Press Release Sep 13 2021
- Press Release Dec 28 2021
- Press Release Dec 30 2021
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India